Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study
2012 ◽
Vol 17
(6)
◽
pp. 844-857
◽
2015 ◽
Vol 31
(4)
◽
pp. 283-293
◽
Keyword(s):
Keyword(s):
Keyword(s):